UPDATE: These are the only 9 stocks Morningstar is fully bullish on
Carl Marks Advisors Bolsters Investment Banking with Promotion of Scott Webb and David Endo
Genexine Releases Positive Interim Phase 2 Clinical Data from PGHD Trial with long-acting growth hormone, GX-H9 at ENDO 2017
Global Reprocessed Medical Devices Market Opportunity, Analysis, Market Shares 2017-2023: Key Players are Cardinal Health, Centurion Medical & GE Healthcare - Research and Markets
Global $442.3 Billion Weight Management (Meals, Beverages, Supplements, Fitness Centers, Slimming Centers, Online Weight Loss Service) Market Analysis 2014-2017 & 2025 - Research and Markets
Time for some game theory: A look at Jazz Pharma's latest settlement
Endo Pharmaceuticals ENDP announced July 11 that it no longer expects to file a new drug application for its ketoprofen pain-relief patch by the first half of 2008 because of lackluster Phase III trial results. The drug candidate failed to show statistically significant results for pain relief in ...